Weave Bio

Weave Bio is an AI-native, cloud-based software company that streamlines regulatory workflows and content preparation for the life sciences industry. Founded in 2022 and headquartered in San Francisco, the company's flagship offering, the Weave Platform, utilizes artificial intelligence to automate the drafting, review, and lifecycle management of complex regulatory dossiers, such as Investigational New Drug (IND) and New Drug Application (NDA) submissions. By infusing AI into every step of the workflow—from data extraction to verification—Weave Bio helps pharmaceutical companies, biotech firms, CROs, and regulatory consultants accelerate submission timelines by over 50% while maintaining strict compliance with global standards. The company has established key partnerships with major industry players like Takeda and Parexel to deploy its AI-driven, human-powered solutions globally.